fda drug shortages tirzepatide zepbound shortage status 2025 confirms is still over, gives compounders a grace period Tirzepatide Shortage Ends - American

In correlation with this, IQVIA data reported a lack of growth between weeks 17 and 20 and even a dip in week 21 (see graph below)

The cap on annual copays is $700, and once you hit it, you wont have to pay any more for your meds

Clinical Considerations Disease-Associated Maternal And/Or Embryo/Fetal Risk Appropriate weight gain based on pre-pregnancy weight is currently recommended for all pregnant patients, including those with obesity or overweight, due to the obligatory weight gain that occurs in maternal tissues during pregnancy

Moriya, R., Shirakura, T., Ito, J., Mashiko, S

Most major insurers cover semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) only after step-therapy protocolsmeaning you must try and fail cheaper alternatives first

Mediterr J Rheumatol